🤩Approach to Renal Amyloidosis https://t.co/sciIcmHFdG @NDTsocial @hjanders_hans

International consensus on post-transplantation diabetes mellitus https://t.co/dsWfZ5Vmpv

Review by Anthony Bleyer et al: Autosomal Dominant Tubulointerstitial Kidney Disease: A Review https://t.co/ZmGIQafBMb (FREE)

💊Anti hypertensives in dialysis @CKJsocial https://t.co/UvtmMVMps2

🧬 "The greatest enemy of knowledge is not ignorance, it is the illusion of knowledge"(SH) The importance of a proper CKD diagnosis and identification of the etiology. 👏🏽 @ecorneclegall at #KidneyWk

How do SGLT2is protect the kidneys? It's simple, let me show you. See? Simple. #KidneyWk

CONFIDENCE: Finerenone with Empagliflozin in CKD and T2D ca. 2025 from @NEJM #Nephpearls #KidneyWk 📌 Among persons with both CKD and T2D, initial therapy with finerenone plus empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio (UACR) than either

Which patients should be on SGLT2 inhibitors (SGLT2i) ⁉️ ✅ Check out the SGLT2i Cold 🥶 Map from @ISNeducation @ISNkidneycare #KidneyWk #Nephpearls 👉🏼 https://t.co/7RhLsx2YTg

Molecular mechanisms in podocytopathies – finding suitable targets for a new era of glomerular gene therapy https://t.co/SQRN9ZA9e1

🦴Osteoporosis Management in CKD https://t.co/4ThEXXZ8aA @CKJsocial

💥Is there an entity called “Fatty Kidney Disease” ⁉️ ⚡️Can kidneys too be obese? Yes indeed ‼️ #NephroNotes #NephPearls #FOAMEd #MedEd

⚡EULAR 2025 Update: Lupus Nephritis (SLE Kidney Involvement) 1️⃣ New Structure: 4 principles + 13 recommendations (evidence-graded). 2️⃣ Core Approach: 🔹 Early biopsy, expert care, & HCQ for all. 🔹 Rheumatology–nephrology team care. 🔹 Aim: prevent CKD, reduce flares, improve

Reducing intradialytic hypotension with intermittent pneumatic compression during hemodialysis: a randomized controlled trial https://t.co/jqCAN5vfRY

💊Drugs to prevent CKD progression https://t.co/jdgpckPUJU @NDTsocial @hjanders_hans

Proposed update to current treatment paradigm for dysregulated vitamin D metabolism in CKD ca. 2025 from @asnpublications #Nephpearls #CKDMBD 👉 https://t.co/Ow7Wo95QOx

Upcoming drug targets for kidney protective effects in chronic kidney disease ➡️This review describes the new and promising treatments for CKD. These therapies hold the potential to slow kidney disease and improve the wellbeing of patients. 🔓 https://t.co/jwah5Fbr6k

Increased risk of cardiac death with cumulative exposure to fluid overload and dialysate sodium ≤ 138 mmol/L in hemodialysis patients https://t.co/lIy64DGkMB

ASN Kidney News August 2025 Special Section on Nutrition - Advancing Potassium Management for Kidney Health: Restricting the Restrictions Maryanne Zilli Canedo Silva, Alice Sabatino , and Carla Maria Avesani https://t.co/AQg4iM1XuP @asnpublications

New formulas for calculating dialysis dose in incremental haemodialysis https://t.co/G5ZrqCTL6t

Core Curriculum by @NephCrit_NM, @hswapnil, @intensivistAk, @OleksaRewa, and @edclark75: Continuous Kidney Replacement Therapies https://t.co/uw7qQXKdOH (FREE)